BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22144477)

  • 1. Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.
    Spinola SM; Li W; Fortney KR; Janowicz DM; Zwickl B; Katz BP; Munson RS
    Infect Immun; 2012 Feb; 80(2):679-87. PubMed ID: 22144477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophilus ducreyi produces a novel sialyltransferase. Identification of the sialyltransferase gene and construction of mutants deficient in the production of the sialic acid-containing glycoform of the lipooligosaccharide.
    Bozue JA; Tullius MV; Wang J; Gibson BW; Munson RS
    J Biol Chem; 1999 Feb; 274(7):4106-14. PubMed ID: 9933604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hd0053 gene of Haemophilus ducreyi encodes an alpha2,3-sialyltransferase.
    Li Y; Sun M; Huang S; Yu H; Chokhawala HA; Thon V; Chen X
    Biochem Biophys Res Commun; 2007 Sep; 361(2):555-60. PubMed ID: 17662691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.
    Young RS; Fortney K; Haley JC; Hood AF; Campagnari AA; Wang J; Bozue JA; Munson RS; Spinola SM
    Infect Immun; 1999 Dec; 67(12):6335-40. PubMed ID: 10569746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and molecular specificity of sialylation of Histophilus somni lipooligosaccharide (LOS) and the effect of LOS sialylation on Toll-like receptor-4 signaling.
    Howard MD; Willis L; Wakarchuk W; St Michael F; Cox A; Horne WT; Hontecillas R; Bassaganya-Riera J; Lorenz E; Inzana TJ
    Vet Microbiol; 2011 Nov; 153(1-2):163-72. PubMed ID: 21482041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of sialylated lipooligosaccharides in Haemophilus ducreyi is dependent on exogenous sialic acid and not mannosamine. Incorporation studies using N-acylmannosamine analogues, N-glycolylneuraminic acid, and 13C-labeled N-acetylneuraminic acid.
    Schilling B; Goon S; Samuels NM; Gaucher SP; Leary JA; Bertozzi CR; Gibson BW
    Biochemistry; 2001 Oct; 40(42):12666-77. PubMed ID: 11601991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.
    Jen FE; Ketterer MR; Semchenko EA; Day CJ; Seib KL; Apicella MA; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33758087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon storage regulator A contributes to the virulence of Haemophilus ducreyi in humans by multiple mechanisms.
    Gangaiah D; Li W; Fortney KR; Janowicz DM; Ellinger S; Zwickl B; Katz BP; Spinola SM
    Infect Immun; 2013 Feb; 81(2):608-17. PubMed ID: 23230298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.
    Janowicz DM; Fortney KR; Katz BP; Latimer JL; Deng K; Hansen EJ; Spinola SM
    Infect Immun; 2004 Aug; 72(8):4528-33. PubMed ID: 15271912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence.
    Bauer BA; Stevens MK; Hansen EJ
    Infect Immun; 1998 Sep; 66(9):4290-8. PubMed ID: 9712780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection.
    Janowicz DM; Zwickl BW; Fortney KR; Katz BP; Bauer ME
    BMC Microbiol; 2014 Jun; 14():166. PubMed ID: 24961160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpsK of Streptococcus agalactiae exhibits alpha2,3-sialyltransferase activity in Haemophilus ducreyi.
    Chaffin DO; McKinnon K; Rubens CE
    Mol Microbiol; 2002 Jul; 45(1):109-22. PubMed ID: 12100552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fibrinogen-binding lipoprotein contributes to the virulence of Haemophilus ducreyi in humans.
    Bauer ME; Townsend CA; Doster RS; Fortney KR; Zwickl BW; Katz BP; Spinola SM; Janowicz DM
    J Infect Dis; 2009 Mar; 199(5):684-92. PubMed ID: 19199547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the Skin Pathogen
    Brothwell JA; Griesenauer B; Chen L; Spinola SM
    Front Immunol; 2020; 11():615402. PubMed ID: 33613541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of N-acetylneuraminic acid into Haemophilus somnus lipooligosaccharide (LOS): enhancement of resistance to serum and reduction of LOS antibody binding.
    Inzana TJ; Glindemann G; Cox AD; Wakarchuk W; Howard MD
    Infect Immun; 2002 Sep; 70(9):4870-9. PubMed ID: 12183531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Haemophilus ducreyi CpxR deletion mutant is virulent in human volunteers.
    Labandeira-Rey M; Dodd D; Fortney KR; Zwickl B; Katz BP; Janowicz DM; Spinola SM; Hansen EJ
    J Infect Dis; 2011 Jun; 203(12):1859-65. PubMed ID: 21606544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A
    Fortney KR; Brothwell JA; Batteiger TA; Duplantier R; Katz BP; Spinola SM
    Infect Immun; 2024 Jun; 92(6):e0005824. PubMed ID: 38780215
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic incorporation of unnatural sialic acids into Haemophilus ducreyi lipooligosaccharides.
    Goon S; Schilling B; Tullius MV; Gibson BW; Bertozzi CR
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3089-94. PubMed ID: 12615992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the Flp proteins by Haemophilus ducreyi is necessary for virulence in human volunteers.
    Janowicz DM; Cooney SA; Walsh J; Baker B; Katz BP; Fortney KR; Zwickl BW; Ellinger S; Munson RS
    BMC Microbiol; 2011 Sep; 11():208. PubMed ID: 21939541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans.
    Young RS; Filiatrault MJ; Fortney KR; Hood AF; Katz BP; Munson RS; Campagnari AA; Spinola SM
    Infect Immun; 2001 Jun; 69(6):4180-4. PubMed ID: 11349097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.